We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfenex Lands HHS Contract to Develop Anthrax Vaccine
Pfenex Lands HHS Contract to Develop Anthrax Vaccine
HHS has contracted with San Diego-based Pfenex Pharmaceuticals to develop an anthrax vaccine that is effective after exposure — under an agreement valued at up to $143 million.